Assignee
Shandong luye pharmaceutical co ltd
CN·8 granted patents·9 pending applications·1 citations·filing 2015–2024
Top patents by PatentIndex Score
17 records- 0171US11110094B2Risperidone sustained release microsphere compositionShandong luye pharmaceutical co ltd·Filed 2019·Granted Sep 7, 2021·0 cites·22 claims
- 0270US10669249B2Rotigotine behenate, and manufacturing method and application thereofShandong luye pharmaceutical co ltd·Filed 2016·Granted Jun 2, 2020·1 cites·16 claims
- 0370US10406161B2Risperidone sustained release microsphere compositionShandong luye pharmaceutical co ltd·Filed 2018·Granted Sep 10, 2019·0 cites·20 claims
- 0464US10098882B2Risperidone sustained release microsphere compositionShandong luye pharmaceutical co ltd·Filed 2016·Granted Oct 16, 2018·0 cites·22 claims
- 0563US9532991B2Risperidone sustained release microsphere compositionShandong luye pharmaceutical co ltd·Filed 2016·Granted Jan 3, 2017·0 cites·19 claims
- 0661US11111227B2Rotigotine behenate, and manufacturing method and application thereofShandong luye pharmaceutical co ltd·Filed 2020·Granted Sep 7, 2021·0 cites·7 claims
- 0759US2025382306A1Heterocyclic compound as taar1 ligand agonistShandong luye pharmaceutical co ltd·Filed 2023·Application pending·0 cites
- 0859US2025368678A119-nor-c3,3-disubstituted c21-azacyclo-substituted steroid and method for using sameShandong luye pharmaceutical co ltd·Filed 2023·Application pending·0 cites
- 0953US2018117123A1Exenatide-containing composition and preparation method thereofShandong luye pharmaceutical co ltd·Filed 2017·Application pending·0 cites
- 1052US10258572B2Pharmaceutical compositions of goserelin sustained release microspheresShandong luye pharmaceutical co ltd·Filed 2017·Granted Apr 16, 2019·0 cites·19 claims
- 1152US2025000864A1Gonadotropin-releasing hormone antagonist, and preparation method therefor and use thereofShandong luye pharmaceutical co ltd·Filed 2022·Application pending·0 cites
- 1248US11124523B22,6-dioxaspiro [4,5] decane derivatives and preparation method therefor and pharmaceutical applications thereofShandong luye pharmaceutical co ltd·Filed 2018·Granted Sep 21, 2021·0 cites·18 claims
- 1347US2022340539A1Compound and preparation method therefor and use thereofShandong luye pharmaceutical co ltd·Filed 2020·Application pending·0 cites
- 1447US2017035856A1Exenatide-containing composition and preparation method thereforShandong luye pharmaceutical co ltd·Filed 2015·Application pending·0 cites
- 1546US2024300971A1Preparation method of 2,6-dioxaspiro [4,5] decane derivatives and salts thereofShandong luye pharmaceutical co ltd·Filed 2024·Application pending·0 cites
- 1645US2021403485A1Pyrazolopyrimidine derivative as selective trk inhibitorShandong luye pharmaceutical co ltd·Filed 2019·Application pending·0 cites
- 1744US2019169140A1Ido1 inhibitor and preparation method and application thereofShandong luye pharmaceutical co ltd·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shandong luye pharmaceutical co ltd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →